Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bradley Winston
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis
Hepatology
Medicine
Hepatology
Related publications
Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients Without Cirrhosis Treated With a Simeprevir/Sofosbuvir/Ledipasvir Regimen
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis
Digestive Diseases and Sciences
Physiology
Gastroenterology
Efficacy and Safety of Generic Daclatasvir + Sofosbuvir ± Ribavirin in Treatment of Genotype 3 Infected Hepatitis C Patients - A Real Life Experience From Pakistan
Hepatoma Research
Improvement of Liver Function in Patients With Decompensated Liver Cirrhosis After Hepatitis C Virus Elimination
Clinical pharmacology and therapy
Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)
Antiviral Therapy
Infectious Diseases
Pharmacology
Editorial: Ribavirin Continues to Play a Role in Treatment With Direct-Acting Antivirals for Hepatitis C Virus-Infected Patients With Decompensated Cirrhosis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis
Hepatoma Research
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
